H A R E S I G N

Primary care management consulting for GP practices and PCNs across England. IGPM Accredited Member.

Contact Info
Connect

LinkedIn

Primary care consulting for GP practices & PCNs across England. Get in touch →

MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd)

Published
23 April 2026
Source
PSNC Dispensing & Supply News
Imported
6 Jun 2026

Update 24/04/2026: Perrigo supplied the incorrect expiry date for one of the batches. This has been corrected in the table below, highlighted in red.  MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) Drug Alert Number: EL(25)A/21 Date issued: 23 April 2026 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant [...]

The post MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) appeared first on Community Pharmacy England.

View Original Alert
Important: This alert is aggregated automatically for information only. Always refer to the original source and follow your practice's own clinical governance procedures.
Get the weekly digest — all new alerts summarised and delivered to your NHS inbox every Monday.
View this week's digest

Back to Safety Alerts

Unlock your Practice Performance Overview

Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.